Paper Details

  1. Home
  2. Paper Details

Cumulative irritation, sensitizing potential, phototoxicity and photoallergy of ozenoxacin in healthy adult volunteers.

Author: CeperoAna Luisa, DosikJonathan S, GropperSavion, LaStellaPhillip, SiemetzkiHeinrich, Wigger-AlbertiWalter

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical Trial, Phase IThe first stage of clinical trials in humans. Evaluates the safety, tolerability, and pharmacokinetics of a new drug/treatment.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study evaluated the safety of ozenoxacin 1 and 2% cream formulations in healthy volunteers. Both formulations were well tolerated and showed little or no tendency to cause irritation, sensitization, phototoxicity, or photoallergy. Only a few adverse events were reported, and virtually all were considered unrelated or unlikely to be related to ozenoxacin application.
Paper Details　
Original Abstract of the Article :
In this series of Phase I, randomized, placebo-controlled studies in healthy volunteers, the potential for ozenoxacin 1 and 2% cream formulations to cause irritation, sensitization, phototoxicity and photoallergy under occlusive patch conditions was evaluated. Both ozenoxacin formulations showed exc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2217/fmb.14.84

データ提供：米国国立医学図書館（NLM）

Ozenoxacin: A Safe and Effective Oasis in the Desert of Skin Care

The development of safe and effective topical treatments for skin conditions is a constant pursuit in dermatological research. This research evaluates the safety profile of ozenoxacin, a topical antibiotic, assessing its potential for irritation, sensitization, phototoxicity, and photoallergy.

A Safe Haven in the Desert of Skin Irritation

This study, like a cool oasis in the desert of skin irritation, demonstrates the excellent dermal tolerability of ozenoxacin cream formulations. The findings suggest that ozenoxacin is well-tolerated, with minimal signs of irritation and no evidence of sensitization, phototoxicity, or photoallergy. This research provides valuable insights into the safety profile of ozenoxacin, paving the way for its potential use in various dermatological applications.

A Journey Towards Clear and Healthy Skin

This research offers hope for individuals seeking safe and effective topical treatments for skin conditions, suggesting that ozenoxacin may be a valuable option. The findings suggest that ozenoxacin is well-tolerated, with minimal risk of irritation or sensitization, making it a potential choice for managing various skin concerns.

Dr. Camel's Conclusion

This study, like a compass guiding us through the desert of skin care, demonstrates the excellent dermal tolerability of ozenoxacin cream formulations. The research suggests that ozenoxacin is a safe and well-tolerated topical antibiotic, offering a potential solution for various dermatological concerns.

Date :
  1. Date Completed 2015-05-18
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

25209521

DOI: Digital Object Identifier

10.2217/fmb.14.84

Related Literature

Article Analysis
・Effects of ozenoxacin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.